1 / 10

Acute Ischemic Stroke Opportunity Analysis

The main driver of the expansion of the acute ischemic stroke (AIS) market will be the launch of Lundbecks next-generation thrombolytic agent desmoteplase, which has an extended therapeutic time window of up to 9 hours post-stroke onset.

sarahjohnsonn
Download Presentation

Acute Ischemic Stroke Opportunity Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Report Insights • The main driver of the expansion of the AIS market will be the launch of Lundbecks next-generation thrombolytic agent desmoteplase, which has an extended therapeutic time window of up to 9 hours post-stroke onset • Other key market drivers include the implementation of telemedicine, rapidly growing and ageing population, resulting in a rise in stroke incidence • Clinical trials attrition in the late-stage pipeline continues to hamper R&D efforts to bring novel therapies onto market, meaning AIS patients are still restricted to few effective treatment options

  2. Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Report Insights (Continued) • Stringent eligibility criteria for thrombolysis treatment, as well as a narrow therapeutic time window, means the majority of AIS patients are currently not treated with Activase/Actilyse • While current thrombolytics are mostly held back by safety concerns when used beyond their intended therapeutic time window, there is ample opportunity for an effective and safe therapy that can be given after nine hours post-stroke onset

  3. Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Report Coverage • Overview of AIS, including epidemiology, etiology, pathophysiology, symptoms, diagnosis and treatment guidelines • Annualized AIS therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2012 and forecast for five years to 2017 • Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the AIS therapeutics market • Pipeline analysis: Focus on the principal late-stage pipeline drug discussing emerging trends as well as overview of earlier phase drugs

  4. Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Report Coverage (Continued) • Analysis of the current and future market competition in the global AIS therapeutics market • Insightful review of the key industry drivers, restraints and challenges • Each trend is independently researched to provide qualitative analysis of its implications

  5. Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Report Benefits • Develop and design in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline • Develop business strategies by understanding the trends shaping and driving the global AIS therapeutics market • Drive revenues by understanding the key trends, innovative products and technologies, market segments, in addition to companies likely to impact the global AIS therapeutics market in future • Formulate effective sales and marketing strategies by understanding the competitive landscape and performance of various competitors

  6. Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Report Benefits (Continued) • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage • Track drug sales in the global AIS therapeutics market from 2012-2017 • Organize sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships

  7. Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Table of Contents • Introduction  • Disease Overview • Epidemiology  • Current Treatment Options • Unmet Needs Assessment and Opportunity Analysis • R&D Strategies • Pipeline Assessment • Pipeline Valuation Analysis • Appendix

  8. Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Report Details • Publish date:Dec 30, 2013 • Number of slides: 162 • Geographic coverage: Global • Available format: PDF, CD, Hardcopy • Price for Single User License: USD 5,995 • Price for Site License: USD 11,990 • Price for Global User License: USD 17,985 • Delivery Time: Within 1 business day • Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal

  9. Interested in this report? To view more details regarding this premium market research report, Please click here For further information, get in touch with us: E-mail: support@researchonglobalmarkets.com Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports

More Related